Cidara Therapeutics, Inc. (CDTX) by event type

CDTX moves most on coverage initiations — a median of -1.73% at 30 minutes across 17 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CDTX overview →

By event type

How CDTX reacts across 4 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst downgrades
1,202 of 2,603
17+0.03%59%+0.05%
Coverage initiations
2,198 of 2,283
17-1.73%35%-0.93%
Rating reiterations
2,841 of 3,522
81-0.17%40%+0.29%
Price-target raises
285 of 1,790
21+0.16%57%+2.36%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.

That’s how CDTX usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · CDTX overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
Brookdale Senior Living Inc. (BKD)341+0.36%62%
Vaxart, Inc. (VXRT)341-0.81%41%
DaVita Inc. (DVA)339+0.07%53%
Lexicon Pharmaceuticals, Inc. (LXRX)339+0.29%51%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.